ABSTRACT
Violence and aggression represent severe social problems, with profound impacts on public health. Despite the development of experimental models to study aggressive behavior is highly appreciated, the underlying mechanisms remain poorly understood. Given the key contribution of mitochondria to central nervous system bioenergetics, we hypothesized that mitochondrial function in brain would be altered by social stress. Using a model of spontaneous aggression, we investigated here the effects of social stress on brain mitochondrial function in prefrontal cortex of Swiss mice. Animals were categorized as highly aggressive, subordinate and non-aggressive (harmonic) after stress induced by regrouping and compared them with non-regrouped animals. Despite social stress did not affect brain cortex oxygen consumption rates and NADH:cytochrome c oxidoreductase activity, cytochrome c oxidase expression and activity were significantly lower in highly aggressive animals compared to non-regrouped ones. These changes were not observed in ATP synthase and adenine nucleotide translocator content suggesting a selective effect of social stress on cytochrome c oxidase. Therefore, aggressive behavior generated upon social stress associates to selective reduction in cytochrome c oxidase activity, with potential detrimental effects on brain bioenergetics and function.
Subject(s)
Aggression/physiology , Cell Respiration/physiology , Cerebral Cortex/enzymology , Electron Transport Complex IV/metabolism , Social Behavior , Stress, Psychological/enzymology , Aggression/psychology , Animals , Enzyme Activation/physiology , Male , Mice , Stress, Psychological/psychologyABSTRACT
Exposure to stress early in life may negatively impact nervous system functioning, including increasing the proneness to learning and memory impairments later in life. Maternal deprivation, a model of early-life stress, hinders memory in adult rats and lessens brain-derived neurotrophic factor (BDNF) levels in the hippocampus in a very heterogeneous way among individuals. The main goal of the present study was to investigate the possible epigenetic modulation underlying recognition memory impairment and reduced BDNF levels in the hippocampus of adult maternally deprived rats. We also evaluated the potential ameliorating properties of the histone deacetylase (HDAC) inhibitor, sodium butyrate, on memory deficits and BDNF changes related to maternal deprivation. Maternally deprived animals were categorized as 'inferior learners' and 'superior learners' according to their performance in object recognition memory task in comparison to controls. Results indicated that HDAC activity was higher in individuals submitted to maternal deprivation with the worst cognitive performance (inferior learners). Acute administration of sodium butyrate increased histone H3 acetylation and BDNF levels, and restored recognition memory in maternally deprived animals with the worst cognitive performance. Moreover, we also showed that there is a positive correlation between BDNF levels and memory performance. Taken together, the results indicated that HDAC inhibitors could be considered as a possible therapeutic agent to improve cognitive performance in inferior learners. Further studies need to be conducted for a better comprehension of the mechanisms related to persistent alterations observed in adult life induced by early stressful circumstances and those leading to resilience.
Subject(s)
Hippocampus/enzymology , Histone Deacetylases/metabolism , Maternal Deprivation , Memory Disorders/enzymology , Recognition, Psychology/physiology , Stress, Psychological/enzymology , Acetylation/drug effects , Animals , Brain-Derived Neurotrophic Factor/metabolism , Butyric Acid/pharmacology , Disease Models, Animal , Hippocampus/drug effects , Hippocampus/growth & development , Histone Deacetylase Inhibitors/pharmacology , Histones/metabolism , Male , Memory Disorders/drug therapy , Nootropic Agents/pharmacology , Rats, Wistar , Recognition, Psychology/drug effectsABSTRACT
Depression is a leading cause of disability worldwide. For this reason, the aim of this study was to investigate the possible antidepressant-like activity of 2-benzoyl-4-iodoselenophene (C17H11IOSe), a selenophene compound, in two well-consolidated behavioral assays for screening antidepressant activity (forced swimming test and tail suspension test) in mice. In order to investigate the mechanism of action of C17H11IOSe, it was investigated the activities of cerebral enzymes: monoamine oxidase MAO A and B and Na+, K+ ATPase, and if an inhibitor of serotonin synthesis, p-chlorophenylalanine (pCPA) (100mg/kg) blocks the antidepressant-like effect of C17H11IOSe. Swiss mice received (C17H11IOSe) (5-50mg/kg) or canola oil by the intragastric (i.g.) route before behavioral tests. The results showed that C17H11IOSe at dose range of 5-50mg/kg decreased immobility time in the tail suspension test. In the forced swimming test, C17H11IOSe reduced the immobility time at the doses of 10 and 50mg/kg. C17H11IOSe differently affected the cerebral cortical Na+, K+ ATPase; the effects on this enzyme were dependent of the dose tested. At a dose of 10mg/kg, the compound increased Na+, K+ ATPase activity, while the activity was inhibited at a dose of 50mg/kg. pCPA blocked the antidepressant-like action of C17H11IOSe in mice. Therefore, C17H11IOSe (5-50mg/kg) selectively inhibited MAO-A activity in cerebral cortices of mice. The modulation of serotonergic system contributed to the antidepressant-like action of C17H11IOSe in mice.
Subject(s)
Antidepressive Agents/administration & dosage , Depressive Disorder/drug therapy , Depressive Disorder/enzymology , Monoamine Oxidase Inhibitors/administration & dosage , Organoselenium Compounds/administration & dosage , Administration, Oral , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Male , Mice , Molecular Structure , Monoamine Oxidase/metabolism , Motor Activity/drug effects , Motor Activity/physiology , Sodium-Potassium-Exchanging ATPase/metabolism , Stress, Psychological/drug therapy , Stress, Psychological/enzymologyABSTRACT
Los problemas éticos de las investigaciones sobre vacunas han crecido en las últimas décadas en frecuencia y magnitud debido a la posición dominante de la industria farmacéutica en el desarrollo de esos estudios. Las tradicionales cuestiones de seguridad y eficacia se han visto agravadas por el conflicto de intereses introducido por la competencia comercial en un mercado a escala global de miles de millones de dólares. La integridad profesional de los investigadores, la responsabilidad moral de los patrocinadores, y la regulación y control por parte de los Estados nacionales, se muestra cuestionada en varios ejemplos. Los resultados de estos cambios son las amenazas a la protección de los derechos de las personas incluidas en estas investigaciones y el discutible progreso que resulta para la salud pública.(AU)
The ethical problems in vaccine research have grown in frequency and magnitude in last decades, due to the dominant place of the pharmaceutical industry in the development of such studies. Traditional issues of security and efficacy have been aggravated by the conflicts of interests introduced by commercial competition in a global market worth billions of dollars. We present here a few examples in which the professional integrity of researchers, the moral responsibility of sponsors, and the public regulation and control by national States are put into question. The consequences of these changes represent serious threats to the rights of people included in these studies as well as disputable progress for public health.(AU)
Subject(s)
Animals , Male , Mice , Benzamides/administration & dosage , Enzyme Inhibitors/administration & dosage , Poly(ADP-ribose) Polymerases/immunology , Stress, Psychological/enzymology , Stress, Psychological/immunology , Analysis of Variance , Antibody Formation/drug effects , Corticosterone/blood , Dose-Response Relationship, Drug , Habituation, Psychophysiologic/physiology , Hemocyanins/immunology , Mice, Inbred C57BL , Poly(ADP-ribose) Polymerases/drug effects , Random Allocation , Restraint, Physical/physiology , Stress, Psychological/bloodABSTRACT
Los problemas éticos de las investigaciones sobre vacunas han crecido en las últimas décadas en frecuencia y magnitud debido a la posición dominante de la industria farmacéutica en el desarrollo de esos estudios. Las tradicionales cuestiones de seguridad y eficacia se han visto agravadas por el conflicto de intereses introducido por la competencia comercial en un mercado a escala global de miles de millones de dólares. La integridad profesional de los investigadores, la responsabilidad moral de los patrocinadores, y la regulación y control por parte de los Estados nacionales, se muestra cuestionada en varios ejemplos. Los resultados de estos cambios son las amenazas a la protección de los derechos de las personas incluidas en estas investigaciones y el discutible progreso que resulta para la salud pública.
The ethical problems in vaccine research have grown in frequency and magnitude in last decades, due to the dominant place of the pharmaceutical industry in the development of such studies. Traditional issues of security and efficacy have been aggravated by the conflicts of interests introduced by commercial competition in a global market worth billions of dollars. We present here a few examples in which the professional integrity of researchers, the moral responsibility of sponsors, and the public regulation and control by national States are put into question. The consequences of these changes represent serious threats to the rights of people included in these studies as well as disputable progress for public health.
Subject(s)
Animals , Male , Mice , Benzamides/administration & dosage , Enzyme Inhibitors/administration & dosage , Poly(ADP-ribose) Polymerases/immunology , Stress, Psychological/enzymology , Stress, Psychological/immunology , Analysis of Variance , Antibody Formation/drug effects , Corticosterone/blood , Dose-Response Relationship, Drug , Habituation, Psychophysiologic/physiology , Hemocyanins/immunology , Poly(ADP-ribose) Polymerases/drug effects , Random Allocation , Restraint, Physical/physiology , Stress, Psychological/bloodABSTRACT
BACKGROUND: The aim of this study was to investigate the involvement of signaling pathways on the creatine antidepressant-like effect in the tail suspension test (TST) in mice. METHODS: The TST was used to assess the antidepressant-like properties of creatine. RESULTS: The anti-immobility effect of creatine (1mg/kg, p.o.) in the TST was blocked by i.c.v. pretreatment with H-89 (1µg/site, PKA inhibitor), KN-62 (1µg/site, CAMK-II inhibitor), chelerythrine (1µg/site, PKC inhibitor), U0126 (5µg/site, MEK1/2 inhibitor) or PD09058 (5µg/site, MEK1/2 inhibitor). CONCLUSION: These results suggest that the antidepressant-like effect of creatine is dependent on PKA, CaMK-II, PKC and MEK 1/2 activation.
Subject(s)
Antidepressive Agents/therapeutic use , Creatine/therapeutic use , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/drug effects , Stress, Psychological/drug therapy , Stress, Psychological/enzymology , Animals , Antidepressive Agents/administration & dosage , Behavior, Animal/drug effects , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Creatine/administration & dosage , Cyclic AMP-Dependent Protein Kinases/metabolism , Disease Models, Animal , Hindlimb Suspension , Injections, Intraventricular , Male , Mice , Mitogen-Activated Protein Kinase Kinases/metabolism , Motor Activity/drug effects , Protein Kinase C/metabolism , Protein Kinase Inhibitors/pharmacologyABSTRACT
Chronic isolation of adult animals represents a form of psychological stress that produces sympatho-adrenomedullar activation. Exercise training acts as an important modulator of sympatho-adrenomedullary system. This study aimed to investigate physical exercise-related changes in gene expression of catecholamine biosynthetic enzymes (tyrosine hydroxylase, dopamine-ß-hydroxylase and phenylethanolamine N-methyltransferase) and cyclic adenosine monophosphate response element-binding (CREB) in the adrenal medulla, concentrations of catecholamines and corticosterone (CORT) in the plasma and the weight of adrenal glands of chronically psychosocially stressed adult rats exposed daily to 20 min treadmill running for 12 weeks. Also, we examined how additional acute immobilization stress changes the mentioned parameters. Treadmill running did not result in modulation of gene expression of catecholamine synthesizing enzymes and it decreased the level of CREB mRNA in the adrenal medulla of chronically psychosocially stressed adult rats. The potentially negative physiological adaptations after treadmill running were recorded as increased concentrations of catecholamines and decreased morning CORT concentration in the plasma, as well as the adrenal gland hypertrophy of chronically psychosocially stressed rats. The additional acute immobilization stress increases gene expression of catecholamine biosynthetic enzymes in the adrenal medulla, as well as catecholamines and CORT levels in the plasma. Treadmill exercise does not change the activity of sympatho-adrenomedullary system of chronically psychosocially stressed rats.
Subject(s)
Adaptation, Physiological/physiology , Adrenal Glands/enzymology , Catecholamines/biosynthesis , Gene Expression Regulation, Enzymologic/physiology , Physical Conditioning, Animal , Stress, Psychological/enzymology , Adrenal Glands/metabolism , Animals , Catecholamines/physiology , Immobilization , Male , Rats , Rats, WistarABSTRACT
RATIONALE: The transition to menopause is associated with an increased risk of depressed mood. OBJECTIVES: This study was conducted to investigate whether diphenyl diselenide [(PhSe)2] treatment could reduce the effects of postmenopausal depression-like behavior in ovariectomized female mice submitted to subchronic stress exposure. METHODS: Mice were divided into four groups: sham, (PhSe)2, ovariectomy (OVX), and OVX + (PhSe)2. Animals were ovariectomized/sham-operated and subjected to stress session once a day for 7 days from the fifth to the 11th day after OVX. The behavioral tests (open field, tail suspension (TST), and forced swimming (FST)) were performed on the 14th day after OVX. Mice were treated orally once a day with vehicle (canola oil, 10 ml/kg) or (PhSe)2 (10 mg/kg; 10 ml/kg) 30 min before being exposed to subchronic stress, or from the 11th to the 14th day. Paroxetine (8 mg/kg i.p.) and pargyline (30 mg/kg i.p.) were used as positive controls. The involvement of serotonergic receptor subtypes in the antidepressant-like effect of (PhSe)2 was assessed in the FST using WAY 100635 (0.1 mg/kg s.c.), ritanserin (1 mg/kg i.p.), and ondansetron (1 mg/kg i.p.) as serotonergic antagonists. Monoamine oxidase (MAO) A and B activities were also determined. RESULTS: The prolongation of immobility time in TST and FST in OVX mice submitted to subchronic stress was prevented by (PhSe)2 treatment. Ritanserin and ondansetron blocked the antidepressive-like effect of (PhSe)2, suggesting the involvement of 5-HT(2A/2C) and 5-HT3 receptor subtypes. Both paroxetine and pargyline were effective in reducing the immobility time of stressed OVX mice in the FST. No alterations in locomotor activity were observed. Although (PhSe)2 had inhibited in vitro MAO-A and MAO-B activities, none of the groups presented alterations neither in ex vivo MAO-A nor in MAO-B activity. CONCLUSIONS: (PhSe)2 treatment could influence mood and behavior, indicating a promising role of this organoselenium compound in the management of postmenopausal depressive symptoms.
Subject(s)
Benzene Derivatives/therapeutic use , Depression/enzymology , Menopause/physiology , Organoselenium Compounds/therapeutic use , Ovariectomy/psychology , Serotonergic Neurons/drug effects , Serotonergic Neurons/enzymology , Stress, Psychological/drug therapy , Animals , Antidepressive Agents/therapeutic use , Benzene Derivatives/antagonists & inhibitors , Benzene Derivatives/pharmacology , Cerebral Cortex/drug effects , Cerebral Cortex/enzymology , Depression/complications , Depression/drug therapy , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Interactions , Female , Hippocampus/drug effects , Hippocampus/enzymology , Immobility Response, Tonic/drug effects , Mice , Mice, Inbred Strains , Mitochondria/enzymology , Monoamine Oxidase/metabolism , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase Inhibitors/therapeutic use , Ondansetron/pharmacology , Organoselenium Compounds/antagonists & inhibitors , Organoselenium Compounds/pharmacology , Pargyline/pharmacology , Pargyline/therapeutic use , Paroxetine/pharmacology , Paroxetine/therapeutic use , Piperazines/pharmacology , Pyridines/pharmacology , Ritanserin , Serotonin Antagonists/pharmacology , Stress, Psychological/complications , Stress, Psychological/enzymologyABSTRACT
In this study, we examined the effects of two chronic stress regimens upon anxiety-like behavior, Na(+), K(+)-ATPase activity and immunocontent, and oxidative stress parameters (antioxidant enzymes and reactive oxygen species production) in the amygdala. Male rats were subjected to chronic unpredictable and to chronic restraint stress for 40 days. Subsequently, anxiety-like behavior was examined. Both stressed groups presented increased anxiety-like behavior. Reduced amygdalal Na(+), K(+)-ATPase activity in the synaptic plasma membranes was also observed, without alterations in the amygdala immunocontent. In addition, when analyzing oxidative stress parameters, only superoxide dismutase activity was decreased in the amygdala of animals subjected to unpredictable stress. We conclude that both models of chronic stress lead to anxiety-like behavior and decreased amygdalal Na(+), K(+)-ATPase activity, which appears not to be related to oxidative imbalance. The relationship between this decreased activity and anxiety-like behavior remains to be studied.
Subject(s)
Amygdala/enzymology , Behavior, Animal/physiology , Sodium-Potassium-Exchanging ATPase/metabolism , Stress, Psychological/enzymology , Animals , Anxiety/etiology , Male , Oxidative Stress/drug effects , Rats , Rats, WistarABSTRACT
Modulation and dysfunction of the glutamatergic system seems to be involved in depression. Recently a renewed interest in the glutamatergic system as a treatment option for major depression emerged by the finding that the glutamate N-methyl-D-aspartate (NMDA) antagonist ketamine leads to a rapid improvement of depressive symptoms. Several works support the hypothesis that metabolism impairment is involved in the pathophysiology of depression. We have also recently reported that mitochondrial respiratory chain complexes I, III and IV were inhibited in cerebral cortex and cerebellum of rats after 40 days of chronic mild stress (CMS), which is used as an animal model of depression. Thus, we investigated whether the inhibition of these enzymes may be reversed by acute administration of ketamine (15 mg/kg). We verified that CMS decreased the intake of sweet food and ketamine was not able to reverse such effect. Adrenal gland weight was increased in stressed rats and ketamine reversed this alteration. Control group gained weight after 40 days but stressed group did not gain weight after the same period. Stressed animals gained weight after acute administration of ketamine, when compared to the body weight assessed at the beginning of the experiment. Finally, we verified that complexes I, III and IV were inhibited after CMS in cerebral cortex and cerebellum and acute administration of ketamine reversed this inhibition. Based on the present findings, we hypothesized that CMS induces inhibition of mitochondrial respiratory chain (complexes I, III and IV) and that acute administration of ketamine reverses such effect.
Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Ketamine/pharmacology , Mitochondria/drug effects , Mitochondria/enzymology , Stress, Psychological/drug therapy , Stress, Psychological/enzymology , Adrenal Glands/drug effects , Adrenal Glands/pathology , Animals , Body Weight/drug effects , Cerebellum/drug effects , Cerebellum/enzymology , Cerebral Cortex/drug effects , Cerebral Cortex/enzymology , Eating/drug effects , Electron Transport/drug effects , Electron Transport/physiology , Electron Transport Complex I/metabolism , Electron Transport Complex III/metabolism , Electron Transport Complex IV/metabolism , Male , Organ Size , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Stress, Psychological/pathologyABSTRACT
Nitric oxide (NO) has been involved in many pathophysiological brain processes. However, the exact role of NO in the cognitive deficit associated to chronic stress exposure has not been elucidated. In this study, we investigated the participation of hippocampal NO production and their regulation by protein kinase C (PKC) in the memory impairment induced in mice subjected to chronic mild stress model (CMS). CMS mice showed a poor learning performance in both open field and passive avoidance inhibitory task respect to control mice. Histological studies showed a morphological alteration in the hippocampus of CMS mice. On the other hand, chronic stress induced a diminished NO production by neuronal nitric oxide synthase (nNOS) correlated with an increment in gamma and zeta PKC isoenzymes. Partial restoration of nNOS activity was obtained after PKC activity blockade. NO production by inducible nitric oxide synthase isoform was not detected. The magnitude of oxidative stress, evaluated by reactive oxygen species production, after excitotoxic levels of NMDA was increased in hippocampus of CMS mice. Moreover, ROS formation was higher in the presence of nNOS inhibitor in both control and CMS mice. Finally, treatment of mice with nNOS inhibitors results in behavioural alterations similar to those observed in CMS animals. These findings suggest a novel role for nNOS showing protective activity against insults that trigger tissue toxicity leading to memory impairments.
Subject(s)
Hippocampus/enzymology , Learning Disabilities/enzymology , Learning Disabilities/psychology , Memory Disorders/enzymology , Memory Disorders/psychology , Nitric Oxide Synthase Type I/physiology , Stress, Psychological/enzymology , Stress, Psychological/psychology , Animals , Avoidance Learning/physiology , Blotting, Western , Chronic Disease , Female , Immunohistochemistry , Isoenzymes/metabolism , Learning Disabilities/etiology , Memory Disorders/etiology , Mice , Mice, Inbred BALB C , N-Methylaspartate/pharmacology , Neuronal Plasticity/physiology , Nitric Oxide/biosynthesis , Nitric Oxide/physiology , Nitric Oxide Synthase Type I/metabolism , Protein Kinase C/metabolism , Protein Kinase C-alpha/metabolism , Protein Kinase C-epsilon/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction/physiology , Stress, Psychological/complicationsABSTRACT
It has been reported that mental stress causes abnormality of spermiogram parameters. We investigated the effect of psychological stress on the L-arginine-nitric oxide (NO) pathway. Semen samples were collected from 29 healthy fourth semester medical students just before (stress) and 3 months after (non-stress) the final examinations. Psychological stress was measured by the State Anxiety Inventory questionnaire. After standard semen analysis, arginase activity and NO concentration were measured spectrophotometrically in the seminal plasma. Measurements were made in duplicate. During the stress period, sperm concentration (41.28 +/- 3.70 vs 77.62 +/- 7.13 x 10(6)/mL), rapid progressive motility of spermatozoa (8.79 +/- 1.66 vs 20.86 +/- 1.63%) and seminal plasma arginase activity (0.12 +/- 0.01 vs 0.22 +/- 0.01 U/mL) were significantly lower than in the non-stress situation, whereas seminal plasma NO (17.28 +/- 0.56 vs 10.02 +/- 0.49 micromol/L) was higher compared to the non-stress period (P < 0.001 for all). During stress there was a negative correlation between NO concentration and sperm concentration, the percentage of rapid progressive motility and arginase activity (r = -0.622, P < 0.01; r = -0.425, P < 0.05 and r = -0.445, P < 0.05, respectively). These results indicate that psychological stress causes an increase of NO level and a decrease of arginase activity in the L-arginine-NO pathway. Furthermore, poor sperm quality may be due to excessive production of NO under psychological stress. In the light of these results, we suggest that the arginine-NO pathway, together with arginase and NO synthase, are involved in semen quality under stress conditions.
Subject(s)
Arginase/analysis , Arginine/metabolism , Nitric Oxide Synthase/metabolism , Semen/enzymology , Spermatozoa/physiology , Stress, Psychological/enzymology , Adult , Humans , Male , Reproducibility of Results , Sperm Count , Sperm Motility , Students, MedicalABSTRACT
It has been reported that mental stress causes abnormality of spermiogram parameters. We investigated the effect of psychological stress on the L-arginine-nitric oxide (NO) pathway. Semen samples were collected from 29 healthy fourth semester medical students just before (stress) and 3 months after (non-stress) the final examinations. Psychological stress was measured by the State Anxiety Inventory questionnaire. After standard semen analysis, arginase activity and NO concentration were measured spectrophotometrically in the seminal plasma. Measurements were made in duplicate. During the stress period, sperm concentration (41.28 ± 3.70 vs 77.62 ± 7.13 x 10(6)/mL), rapid progressive motility of spermatozoa (8.79 ± 1.66 vs 20.86 ± 1.63 percent) and seminal plasma arginase activity (0.12 ± 0.01 vs 0.22 ± 0.01 U/mL) were significantly lower than in the non-stress situation, whereas seminal plasma NO (17.28 ± 0.56 vs 10.02 ± 0.49 æmol/L) was higher compared to the non-stress period (P < 0.001 for all). During stress there was a negative correlation between NO concentration and sperm concentration, the percentage of rapid progressive motility and arginase activity (r = -0.622, P < 0.01; r = -0.425, P < 0.05 and r = -0.445, P < 0.05, respectively). These results indicate that psychological stress causes an increase of NO level and a decrease of arginase activity in the L-arginine-NO pathway. Furthermore, poor sperm quality may be due to excessive production of NO under psychological stress. In the light of these results, we suggest that the arginine-NO pathway, together with arginase and NO synthase, are involved in semen quality under stress conditions.
Subject(s)
Adult , Humans , Male , Arginase/analysis , Arginine/metabolism , Nitric Oxide Synthase/metabolism , Semen/enzymology , Spermatozoa/physiology , Stress, Psychological/enzymology , Reproducibility of Results , Sperm Count , Sperm Motility , Students, MedicalABSTRACT
Stress activates the synthesis and secretion of catecholamines and adrenal glucocorticoids, increasing their circulating levels. In vivo, hepatic 11beta-hydroxysteroid dehydrogenase 1 (HSD1) stimulates the shift of 11-dehydrocorticosterone to corticosterone, enhancing active glucocorticoids at tissue level. We studied the effect of 3 types of stress, 1 induced by bucogastric overload with 200 mmol/L HCl causing metabolic acidosis (HCl), the second induced by bucogastric overload with 0.45% NaCl (NaCl), and the third induced by simulated overload (cannula), on the kinetics of hepatic HSD1 of rats and their influence on the activity of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase, glycemia, and glycogen deposition. Compared with unstressed controls, all types of stress significantly increased HSD1 activity (146% cannula, 130% NaCl, and 253% HCl), phosphoenolpyruvate carboxykinase activity (51% cannula, 48% NaCl, and 86% HCl), and glycemia (29% cannula, 30% NaCl, and 41% HCl), but decreased hepatic glycogen (68% cannula, 68% NaCl, and 78% HCl). Owing to these results, we suggest the following events occur when stress is induced: an increase in hepatic HSD1 activity, augmented active glucocorticoid levels, increased gluconeogenesis, and glycemia. Also involved are the multiple events indirectly related to glucocorticoids, which lead to the depletion of hepatic glycogen deposits, thereby contributing to increased glycemia. This new approach shows that stress increments the activity of hepatic HSD1 and suggests that this enzyme could be involved in the development of the Metabolic Syndrome.
Subject(s)
11-beta-Hydroxysteroid Dehydrogenases/metabolism , Carbohydrate Metabolism/physiology , Liver/enzymology , Liver/metabolism , Stress, Psychological/enzymology , 11-beta-Hydroxysteroid Dehydrogenase Type 1/metabolism , Animals , Blood Glucose/metabolism , Corticosterone/pharmacology , Cytosol/enzymology , Gluconeogenesis/drug effects , Gluconeogenesis/physiology , Kinetics , Liver/drug effects , Liver Glycogen/metabolism , Male , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Phosphoenolpyruvate Carboxykinase (ATP)/metabolism , Rats , Rats, Sprague-DawleyABSTRACT
This study was undertaken to verify the effects of chronic stress and lithium treatments on the hippocampal Na+,K(+)-ATPase activity of rats, as well as to investigate the effects of stress interruption and post-stress lithium treatment on this enzyme activity and on spatial memory. Two experiments were carried out; in the first experiment, adult male Wistar rats were divided into two groups: control and submitted to a chronic variate stress paradigm, and subdivided into treated or not with LiCl. After 40 days of treatment, rats were killed, and Na+,K(+)-ATPase activity was determined. In the second experiment, rats were stressed during 40 days, and their performance was evaluated in the Water Maze task. The stressed group was then subdivided into four groups, with continued or interrupted stress treatment and treated or not with lithium for 30 additional days. After a second evaluation of performance in the Water Maze, rats were killed and Na+,K(+)-ATPase activity was also measured. Results showed an impairment in Na+,K(+)-ATPase activity and in Water Maze performance of chronically stressed rats, which were prevented by lithium treatment and reversed by lithium treatment and by stress interruption. These results suggest that the modulation of Na+,K(+)-ATPase activity may be one of the mechanisms of action of lithium in the treatment of mood disorders.
Subject(s)
Antidepressive Agents/administration & dosage , Depression/enzymology , Hippocampus/enzymology , Lithium/administration & dosage , Sodium-Potassium-Exchanging ATPase/metabolism , Stress, Psychological/enzymology , Analysis of Variance , Animals , Chronic Disease , Depression/complications , Depression/drug therapy , Disease Models, Animal , Drug Administration Schedule , Hippocampus/cytology , Hippocampus/drug effects , Learning Disabilities/complications , Learning Disabilities/enzymology , Male , Neurons , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/drug effects , Stress, Psychological/complications , Stress, Psychological/drug therapy , Synaptic Membranes/drug effects , Synaptic Membranes/enzymologyABSTRACT
Stimulation of the hippocampal formation can modulate nociceptive mechanisms, whereas painful stimuli can activate this structure. Stress exposure can produce plastic changes in the hippocampus. Nitric oxide (NO) is an important neuroregulatory agent present in the hippocampus. The objective of the present study was to investigate the effects of intrahippocampal administration of N(omega)-nitro-L-arginine methyl ester hydrochloride (L-NAME), an inhibitor of NO synthase (NOS), on nociceptive processes in stressed and nonstressed rats. Male Wistar rats (n=6-11/group) received unilateral microinjection of L-NAME (50-300 nmol/0.2 microl) into the dentate gyrus (DG) of the dorsal hippocampus. Immediately after the injection tail-flick reflex latency was measured. Stressed animals were submitted to 2 h of restraint and tested immediately or 1, 2, 5 or 10 days later. L-NAME failed to modify nociception in nonstressed rats. However, 5 days after, restraint L-NAME, at all doses tested, produced an antinociceptive effect (ANOVA, P<.05). The dose-response curve had an inverted U shape. L-NAME antinociceptive effect was antagonized by previous treatment with L-arginine (150 nmol/0.2 microl, P<.05). The results suggest that the modulation of nociceptive processes by NO in the dorsal hippocampus is dependent on previous stress exposure and on poststress interval.
Subject(s)
Dentate Gyrus/enzymology , Enzyme Inhibitors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide/physiology , Stress, Psychological/enzymology , Stress, Psychological/psychology , Animals , Dentate Gyrus/drug effects , Dose-Response Relationship, Drug , Male , Microinjections , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase Type I , Pain Measurement/drug effects , Rats , Rats, Wistar , Reaction Time/drug effects , Restraint, Physical , Stereotaxic TechniquesABSTRACT
We have previously observed that, while acute stress induces analgesia, chronic stress causes a hyperalgesic response in male rats. No effect was observed in females. There is increasing evidence that both ATP and adenosine can modulate pain. Extracellular ATP and ADP are hydrolyzed by an apyrase in synaptosomes from the peripheral and central nervous systems. In the present study, we investigated the effect of chronic and acute stress on ATPase-ADPase and 5'-nucleotidase activities in spinal cord of male and female rats. Adult male and female Wistar rats were submitted to 1 h restraint stress/day for 1 day (acute) or 40 days (chronic) and were sacrificed 24 h later. ATPase-ADPase activities were assayed in the synaptosomal fraction obtained from the spinal cord of control and stressed animals. ADP hydrolysis was decreased 25% in chronically stressed males, while no change was observed on ATPase activity. There was an increase in the 5'-nucleotidase activity in the same group. No effect on ADPase, ATPase or on 5'-nucleotidase activity was observed in females with chronic stress, or after acute stress neither in males or females. Chronic stress reduced ADP hydrolysis and increased 5'-nucleotidase activity in the spinal cord in male rats.
Subject(s)
Nucleotidases/metabolism , Spinal Cord/enzymology , Stress, Psychological/enzymology , 5'-Nucleotidase/metabolism , Acute Disease , Adenosine Triphosphatases/metabolism , Animals , Apyrase/metabolism , Chronic Disease , Female , Male , Rats , Rats, Wistar , Restraint, Physical , Sex Characteristics , Subcellular Fractions/enzymology , Synaptosomes/metabolismABSTRACT
Nitric oxide (NO) has been shown to be an important modulator of the febrile response to pyrogens and to psychological stress. In the present study, we aimed to identify the nitric oxide synthase (NOS) isoform (neuronal or inducible, nNOS and iNOS, respectively) involved in restraint stress fever. Colonic temperature (Tc) was measured in unanesthetized rats before and after treatment with the more selective nNOS inhibitor 7-nitroindazole or with the selective iNOS inhibitor aminoguanidine (AG) under unrestrained or restrained conditions. Intraperitoneal injection of AG (25 or 50 mg/kg) did not affect restraint fever, indicating that iNOS is unlikely to be involved in restraint fever. On the other hand, intraperitoneal injection of 7-nitroindazole (25 mg/kg) significantly attenuated the rise in the Tc caused by restraint stress, whereas it caused no change in Tc of euthermic animals. These data show that NO produced by nNOS plays an important role in the genesis of restraint stress-induced fever.
Subject(s)
Fever/enzymology , Nitric Oxide Synthase/physiology , Stress, Psychological/enzymology , Animals , Body Temperature/drug effects , Enzyme Inhibitors/pharmacology , Fever/etiology , Guanidines/pharmacology , Indazoles/pharmacology , Injections, Intraperitoneal , Male , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type I , Nitric Oxide Synthase Type II , Rats , Rats, Wistar , Restraint, Physical , Stress, Psychological/complicationsABSTRACT
Compelling evidence has indicated the involvement of extracellular ATP and adenosine in the mechanisms of synaptic plasticity and memory formation. In the present study, adult rats were trained in a step-down inhibitory avoidance task (IA) or submitted to isolated foot-shock (IF) (0.4 mA) before measuring ectonucleotidase activities in the synaptosomes of the anterior and posterior cingulate cortex (AC and PC, respectively) and the medial precentral area (Fr2). IA increased ATP and ADP hydrolysis immediately after training in the synaptosomes of PC and AC, respectively, (P<0.05). Foot-shock (independent of occurring during IA or IF) increased ATP hydrolysis in synaptosomes of AC and Fr2 immediately after application and decreased AIP hydrolysis in AC 90 min after application (P<0.05). Foot-shock (independent of occurring during IA or IF) increased ATP hydrolysis in PC immediately and 90 min after application, and in Fr2, but only immediately after application (P<0.05). These results suggest that the ectonucleotidase pathway responds to a mild foot-shock in AC, PC and Fr2 and may be involved in memory consolidation of step-down inhibitory avoidance in the cingulate cortex.
Subject(s)
Avoidance Learning/physiology , Cerebral Cortex/enzymology , Nucleotidases/metabolism , Prefrontal Cortex/enzymology , Stress, Psychological/enzymology , Stress, Psychological/psychology , Synaptosomes/enzymology , Adenosine/biosynthesis , Adenosine/physiology , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Animals , Electroshock , Hydrolysis , Male , Memory/physiology , Rats , Rats, Wistar , Subcellular Fractions/enzymologyABSTRACT
1. The effect of benzodiazepine pretreatment on the stress-induced decrease in MAO activity in rat tissues using footshock as stress model was investigated. 2. Animals were injected with vehicle, Lorazepam (1.25 mg/kg), or Clonazepam (0.5 mg/kg) 2 hr before or with PK 11195 (0.45 mg/kg) 2.5 hr before being subjected to one session of 10 inescapable footshocks or to a sham session. At the end of the session animals were sacrificed and MAO A and B activities in hearts and brains were determined. 3. Pretreatment of the animals with both Lorazepam and Clonazepam abolished the decrease induced by footshock in MAO A activity in brain. Pretreatment with Lorazepam but not with Clonazepam abolished the stress-induced decrease in MAO A in the heart. Pretreatment with PK 11195 before Lorazepam reversed its effects in the heart but not in the brain. Neither footshock nor any of the drugs used had any effect on heart and brain MAO B. 4. Our results suggest that in the heart but not in the brain, peripheral benzodiazepine receptors play a role in the regulation of MAO A activity under stress conditions.